Filtrovat podle Last updated date SelectpopředFrom - To Datum Datum ukončení Tento týden Tento měsíc Minulý týden Minulý měsíc Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Výsledky (3794) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Assessment of human dietary exposure to residues of veterinary medicines in the EU 19 Leden 2023 News Human Veterinary Medicines Mandatory use of CTIS from 31 January 2023 for all new clinical trial applications 19 Leden 2023 News Human Clinical trials Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9 - 12 January 2023 13 Leden 2023 News Human Pharmacovigilance Referrals EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders 13 Leden 2023 News Human Referrals End-of-year message from EMA’s Executive Director 21 Prosinec 2022 News Corporate EMA business hours over holiday period 20 Prosinec 2022 News Corporate COVID-19 Facilitating Decentralised Clinical Trials in the EU 19 Prosinec 2022 News Human Clinical trials EMA Management Board: highlights of December 2022 meeting 16 Prosinec 2022 News Corporate Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 December 2022 16 Prosinec 2022 News Human COVID-19 Medicines First gene therapy to treat haemophilia B 16 Prosinec 2022 News Human Medicines 1 … 31 32 33 34 35 Page 35 of 380 36 37 38 39 … 380
Assessment of human dietary exposure to residues of veterinary medicines in the EU 19 Leden 2023 News Human Veterinary Medicines
Mandatory use of CTIS from 31 January 2023 for all new clinical trial applications 19 Leden 2023 News Human Clinical trials
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9 - 12 January 2023 13 Leden 2023 News Human Pharmacovigilance Referrals
EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders 13 Leden 2023 News Human Referrals
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 December 2022 16 Prosinec 2022 News Human COVID-19 Medicines